Preclinical pharmacokinetic profiling of IQG‐607, a potential oral metallodrug to treat tuberculosis
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Pharmaceutical Sciences"
DOI: 10.1016/j.ejps.2017.10.020
Abstract: ABSTRACT IQG‐607 is an analog of isoniazid with anti‐tuberculosis activity. This work describes the development and validation of an HPLC method to quantify pentacyano(isoniazid)ferrate(II) compound (IQG‐607) and the pharmacokinetic studies of this compound in mice.… read more here.
Keywords: pharmacokinetic profiling; treat; preclinical pharmacokinetic; iqg ... See more keywords